1101 related articles for article (PubMed ID: 31060120)
1. 2018 Korean Liver Cancer Association-National Cancer Center Korea Practice Guidelines for the Management of Hepatocellular Carcinoma.
;
Gut Liver; 2019 May; 13(3):227-299. PubMed ID: 31060120
[TBL] [Abstract][Full Text] [Related]
2. 2018 Korean Liver Cancer Association-National Cancer Center Korea Practice Guidelines for the Management of Hepatocellular Carcinoma.
;
Korean J Radiol; 2019 Jul; 20(7):1042-1113. PubMed ID: 31270974
[TBL] [Abstract][Full Text] [Related]
3. 2022 KLCA-NCC Korea Practice Guidelines for the Management of Hepatocellular Carcinoma.
Korean Liver Cancer Association (KLCA) and National Cancer Center (NCC) Korea
Korean J Radiol; 2022 Dec; 23(12):1126-1240. PubMed ID: 36447411
[TBL] [Abstract][Full Text] [Related]
4. 2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma.
Korean Liver Cancer Association (KLCA) and National Cancer Center (NCC) Korea
Clin Mol Hepatol; 2022 Oct; 28(4):583-705. PubMed ID: 36263666
[TBL] [Abstract][Full Text] [Related]
5. 2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma.
Korean Liver Cancer Association (KLCA) and National Cancer Center (NCC) Korea
J Liver Cancer; 2023 Mar; 23(1):1-120. PubMed ID: 37384024
[TBL] [Abstract][Full Text] [Related]
6. Noninvasive Diagnosis of Hepatocellular Carcinoma: Elaboration on Korean Liver Cancer Study Group-National Cancer Center Korea Practice Guidelines Compared with Other Guidelines and Remaining Issues.
Yoon JH; Park JW; Lee JM
Korean J Radiol; 2016; 17(1):7-24. PubMed ID: 26798212
[TBL] [Abstract][Full Text] [Related]
7. Revised Korean Antiviral Guideline Reduces the Hepatitis B-related Hepatocellular Carcinoma Risk in Cirrhotic Patients.
Kim DS; Park SY; Kim BK; Park JY; Kim DY; Han KH; Lee YR; Tak WY; Kweon YO; Jung I; Han M; Kim EH; Ahn SH; Kim SU
J Korean Med Sci; 2021 Apr; 36(16):e105. PubMed ID: 33904261
[TBL] [Abstract][Full Text] [Related]
8. Clinical practice guideline and real-life practice in hepatocellular carcinoma: A Korean perspective.
Goh MJ; Sinn DH; Kim JM; Lee MW; Hyun DH; Yu JI; Hong JY; Choi MS
Clin Mol Hepatol; 2023 Apr; 29(2):197-205. PubMed ID: 36603575
[TBL] [Abstract][Full Text] [Related]
9. Predictive Value of Antiviral Effects in the Development of Hepatocellular Carcinoma in the General Korean Population with Chronic Hepatitis B.
Shim JJ; Oh IH; Kim SB; Kim JW; Lee CK; Jang JY; Lee JS; Kim BH
Gut Liver; 2016 Nov; 10(6):962-968. PubMed ID: 27282260
[TBL] [Abstract][Full Text] [Related]
10. Pathogenic mechanisms in HBV- and HCV-associated hepatocellular carcinoma.
Arzumanyan A; Reis HM; Feitelson MA
Nat Rev Cancer; 2013 Feb; 13(2):123-35. PubMed ID: 23344543
[TBL] [Abstract][Full Text] [Related]
11. HBV + HCV = HCC?
Cramp ME
Gut; 1999 Aug; 45(2):168-9. PubMed ID: 10403725
[No Abstract] [Full Text] [Related]
12. 2014 Korean Liver Cancer Study Group-National Cancer Center Korea practice guideline for the management of hepatocellular carcinoma.
;
Korean J Radiol; 2015; 16(3):465-522. PubMed ID: 25995680
[TBL] [Abstract][Full Text] [Related]
13. Oncogenic viruses and hepatocellular carcinoma.
Ben Ari Z; Weitzman E; Safran M
Clin Liver Dis; 2015 May; 19(2):341-60. PubMed ID: 25921667
[TBL] [Abstract][Full Text] [Related]
14. Hepatitis viruses and hepatocellular carcinoma.
Kew MC
Res Virol; 1998; 149(5):257-62. PubMed ID: 9879602
[No Abstract] [Full Text] [Related]
15. Low adherence of HIV providers to practice guidelines for hepatocellular carcinoma screening in HIV/hepatitis B coinfection.
Hearn B; Chasan R; Bichoupan K; Suprun M; Bagiella E; Dieterich DT; Perumalswami P; Branch AD; Huprikar S
Clin Infect Dis; 2015 Dec; 61(11):1742-8. PubMed ID: 26240206
[TBL] [Abstract][Full Text] [Related]
16. [Current status and clinical course of hepatitis C virus in Korea].
Kwon JH; Bae SH
Korean J Gastroenterol; 2008 Jun; 51(6):360-7. PubMed ID: 18604137
[TBL] [Abstract][Full Text] [Related]
17. [Practice guidelines for management of hepatocellular carcinoma 2009].
Korean Liver Cancer Study Group and National Cancer Center, Korea
Korean J Hepatol; 2009 Sep; 15(3):391-423. PubMed ID: 19783891
[TBL] [Abstract][Full Text] [Related]
18. Viral hepatitis and liver cancer in Korea: an epidemiological perspective.
Yeo Y; Gwack J; Kang S; Koo B; Jung SJ; Dhamala P; Ko KP; Lim YK; Yoo KY
Asian Pac J Cancer Prev; 2013; 14(11):6227-31. PubMed ID: 24377509
[TBL] [Abstract][Full Text] [Related]
19. Clinicopathologic characteristics andoutcomes of hepatocellular carcinoma associated with chronic hepatitis B versus hepatitis C infection.
Aljumah AA; Kuriry H; Faisal N; Alghamdi H
Ann Saudi Med; 2018; 38(5):358-365. PubMed ID: 30284991
[TBL] [Abstract][Full Text] [Related]
20. 2014 KLCSG-NCC Korea Practice Guideline for the Management of Hepatocellular Carcinoma.
;
Gut Liver; 2015 May; 9(3):267-317. PubMed ID: 25918260
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
